| 3P Biopharmaceuticals S.L.. (7/23/19). "Press Release: 3P Biopharmaceuticals Welcomes Keensight Capital as Majority Shareholder". Paris. |
2019-07-23 |
| ABAC Therapeutics. (2/15/18). "Press Release: ABAC Therapeutics Announces €16 Million Series A to Develop Therapeutic Solutions to Fight Antibiotic-resistant Bacteria". Barcelona. |
2018-02-15 |
| Ability Pharmaceuticals S.L.. (9/18/17). "Press Release: Ability Pharmaceuticals Announces EMA-Orphan Drug Designation for ABTL0812 in Pancreatic Cancer". Barcelona. |
2017-09-18 |
| Abivax S.A.. (12/7/17). "Press Release: Abivax to Present in Plenary Session at the 8th International Conference on HIV Persistence during Therapy". Paris. |
2017-12-07 |
| Abivax S.A.. (5/2/17). "Press Release: First Ever Evidence of Treatment-induced Reduction in HIV Reservoirs". Paris. |
2017-05-02 |
| Abivax S.A.. (9/18/17). "Press Release: First Patient Dosed in Three-month Cohort of Phase 2A Study of Oral ABX464 in HIV-supressed Patients". Paris. |
2017-09-18 |
| Aboleris Pharma. (9/18/23). "Press Release: Aboleris Pharma Announces €27 Million in Series A Financing to Advance its Novel Treatment Paradigm for Autoimmune and Inflammatory Diseases". Gosselies. |
2023-09-18 |
| Accure Therapeutics. (5/26/20). "Press Release: Accure Therapeutics Launches with €7.6M Series A Round". Barcelona. |
2020-05-26 |
| Adaptimmune Ltd.. (9/30/19). "Press Release: Clear Benefit for Patients with Synovial Sarcoma Demonstrated in Updated Data from Ongoing Phase 1 Trial with ADP-A2M4 Presented at ESMO". Philadeliphia, PA & Oxfordshire. |
2019-09-30 |
| Advanced Chemistry Development, Inc. (ACD/Labs). (3/20/18). "Press Release: ACD/Labs Files Lawsuit for Copyright Infringement against MestreLab Research". Toronto. |
2018-03-20 |
| Advent France Biotechnology SAS. (3/17/21). "Press Release: Advent France Biotechnology Appoints Alejo Chorny, PhD, as Operating Partner and Head of New Spanish Operations". Paris & Barcelona. |
2021-03-17 |
| Aelix Therapeutics S.L.. (10/18/18). "Press Release: Aelix Therapeutics and Gilead Sciences Enter into a Clinical Research Collaboration Agreement to Evaluate a Therapeutic Vaccine and TLR7 Agonist Regimen for HIV Cure". |
2018-10-18 |
| Aelix Therapeutics S.L.. (10/20/17). "Press Release: Aelix Therapeutics Appoints Dr. Thomas Hecht as Chairman of the Board of Directors". |
2017-10-20 |
| Aelix Therapeutics S.L.. (9/5/17). "Press Release: Aelix Therapeutics Enrolls First Patient in Company’s Initial Therapeutic HIV Vaccine Clinical Trial". |
2017-09-05 |
| Agomab Therapeutics N.V.. (10/28/21). "Press Release: Agomab Therapeutics to Acquire Origo Biopharma". Ghent. |
2021-10-28 |
| Algenex S.L.. (3/5/19). "Press Release: Algenex Closes Funding Round and Strengthens Team with Key Senior Manager Appointments". Madrid. |
2019-03-05 |
| Algenex S.L.. (9/8/20). "Press Release: Algenex Raises €7.4 Million in Financing Round". Madrid. |
2020-09-08 |
| Alimera Sciences, Inc.. (3/13/17). "Press Release: Alimera Sciences Signs Agreement for Exclusive Distributor of Iluvien in Spain". Atlanta, GA. |
2017-03-13 |
| Allergy Therapeutics plc. (9/28/17). "Press Release: Preliminary Results". |
2017-09-28 |
| Almirall S.A.. (1/9/20). "Press Release: Almirall and WuXi Biologics Sign Strategic Collaboration Agreement for Multiple Bispecific Antibodies Targeting Dermatology Diseases". Barcelona. |
2020-01-09 |
| Almirall S.A.. (1/9/20). "Press Release: Almirall Enters into an Option Agreement to Acquire Bioniz Therapeutics and to Establish a Broad Research Agreement to Further Expand Its Innovative Pipeline in Medical Dermatology". Barcelona. |
2020-01-09 |
| Almirall S.A.. (1/9/20). "Press Release: Almirall Signs a Strategic Agreement with 23andMe to License Rights of a Bispecific Monoclonal Antibody that Blocks All Three Isoforms of IL-36 Cytokine". Barcelona & Sunnyvale, CA. |
2020-01-09 |
| Almirall S.A.. (11/14/23). "Press Release: Almirall and Absci Announce AI Drug Discovery Partnership to Rapidly Develop Novel Treatments for Dermatological Diseases". Barcelona & Vancouver, WA. |
2023-11-14 |
| Almirall S.A.. (12/14/21). "Press Release: Ichnos Sciences and Almirall Enter into a Licensing Agreement for First-in-Class IL-1RAP Antagonist Monoclonal Antibody". New York, NY & Barcelona. |
2021-12-14 |
| Almirall S.A.. (2/17/21). "Press Release: Almirall and MC2 Therapeutics Enter a License, Collaboration and Commercialization Agreement for European Rights to Wynzora Cream for Treatment of Plaque Psoriasis". Barcelona & Copenhagen. |
2021-02-17 |
| Almirall S.A.. (2/3/21). "Press Release: Almirall Announces Gianfranco Nazzi as New CEO". |
2021-02-03 |
| Almirall S.A.. (8/28/17). "Press Release: Almirall Appoints Peter Guenter as New CEO". Barcelona. |
2017-08-28 |
| Amcure GmbH. (8/23/17). "Press Release: Amcure Announces Formation of Inaugural Scientific Advisory Board". Eggenstein-Leopoldshafen. |
2017-08-23 |
| Applied Photophysics Ltd.. (5/15/18). "Press Release: Applied Photophysics Signs Agreements with Alfatest and Paralab to Expand Distribution in Europe". Surrey, Rome & Valborn. |
2018-05-15 |
| AptaTargets. (5/17/17). "Press Release: AptaTargets Closes €2.7 Million Round of Funding for New Stroke Treatment". Madrid. |
2017-05-17 |
| Arcis Biotechnology Ltd.. (7/16/19). "Press Release: Arcis Biotechnology and Mirnax Biosens Sign Exclusive License Agreement for Arcis Sample Prep Technology". Daresbury & Madrid. |
2019-07-16 |
| Artax Biopharma, Inc.. (6/4/20). "Press Release: Artax Biopharma Announces Series B Financing Extension to Advance First-in-Class Autoimmune Disease Therapy". Cambridge, MA. |
2020-06-04 |
| Asabys Partners. (9/15/22). "Press Release: Asabys Launches a New €200m Fund to Invest in Biotech & Healthtech". |
2022-09-15 |
| BCN Health Venture Partners S.L. (BHV Partners). (12/22/23). "Press Release: BHV Partners Appoints Albert Mascarell as New CEO". Barcelona. |
2023-12-22 |
| Becton, Dickinson and Company. (5/18/21). "Press Release: BD to Build New €165 Million Manufacturing Facility in Zaragoza, Spain to Support Ongoing Strong Growth of Pre-Filled Drug Delivery Business". Madrid. |
2021-05-18 |
| Biocat. (10/14/21). "Press Release: Robert Fabregat, New CEO of Biocat". Barcelona. |
2021-10-14 |
| Biocat. (10/21/19). "Press Release: Boehringer Ingelheim Joins the d·HEALTH Barcelona Program to Foster Innovation in Health". Barcelona. |
2019-10-21 |
| Biocat. (3/27/20). "Press Release: Barcelona to Host BIO-Europe Spring 2021". Barcelona. |
2020-03-27 |
| BioClin Therapeutics, Inc.. (3/22/17). "Press Release: BioClin Therapeutics, Inc., Raises $30 Million in Series B Financing Led by Sofinnova Ventures and Ysios Capital". San Ramon, CA. |
2017-03-22 |
| Bioncotech Therapeutics S.L.. (12/10/19). "Press Release: Bioncotech Therapeutics Announces Oncology Clinical Trial Collaboration with MSD. Phase II Trial with Combination of BO-112 and Pembrolizumab". Madrid. |
2019-12-10 |
| Bioncotech Therapeutics S.L.. (12/12/19). "Press Release: Bioncotech Therapeutics Phase I BO-112 Data Presented at ESMO Immuno-Oncology Congress 2019". Madrid. |
2019-12-12 |
| Bionure. (5/16/18). "Press Release: Bionure Initiates a Phase 1 Clinical Trial of Its Lead Compound BN201 in the United Kingdom". Barcelona. |
2018-05-16 |
| Biotest AG. (4/25/22). "Press Release: Grifols Acquires Majority of Voting Rights in Biotest". Dreieich. |
2022-04-25 |
| Bristol-Myers Squibb Company. (8/19/21). "Press Release: Bristol Myers Squibb Receives European Commission Approval for Abecma (Idecabtagene Vicleucel), the First Anti-BCMA CAR T Cell Therapy for Relapsed and Refractory Multiple Myeloma". Princeton, NJ. |
2021-08-19 |
| Bruker Corporation. (12/13/18). "Press Release: Bruker and Mestrelab Announce Strategic Collaboration and Partnership for Chemistry and Pharma Software Applications". Billerica, MA. |
2018-12-13 |
| Bruker Corporation. (4/20/18). "Press Release: Bruker Introduces Bologna Workflow for Rapid and Cost-Effective Clinical Microbiology Diagnosis of Bloodstream Infections with Broad Species Coverage". Madrid. |
2018-04-20 |
| Catalan Institute of Nanoscience and Nanotechnology (ICN2(. (6/11/20). "Press Release: New Investors for Inbrain to Develop Graphene-based Implants against Brain Disorders". |
2020-06-11 |
| Cellnovo. (6/29/17). "Press Release: Cellnovo Expands International Distribution Network". Paris. |
2017-06-29 |
| Coriolis Pharma Research GmbH. (5/4/22). "Press Release: Coriolis Pharma Appoints Silvia Steyrer-Gruber as New Chief Executive Officer". Martinsried. |
2022-05-04 |
| CRISPR Therapeutics AG. (9/17/19). "Press Release: CRISPR Therapeutics and ViaCyte Present Positive In Vitro Data Towards a Potential Immune-Evasive Cell Replacement Therapy for Diabetes at EASD 2019". Zug, Cambridge, MA & San Diego, CA. |
2019-09-17 |
| Curetis N.V.. (4/18/18). "Press Release: Curetis – Novel Products and Study Data to Be Presented at ECCMID 2018". Amsterdam, San Diego, CA & Holzgerlingen. |
2018-04-18 |
| Curetis N.V.. (4/19/18). "Press Release: Curetis Launches CE-IVD Marked Unyvero Urinary Tract Infection (UTI) Cartridge at ECCMID 2018". Amsterdam, San Diego, CA & Holzgerlingen. |
2018-04-19 |
| Cytoki Pharma ApS. (5/5/21). "Press Release: Cytoki Pharma Raises $45 Million Series A Financing". Copenhagen. |
2021-05-05 |
| Devicare S.L.. (5/3/19). "Press Release: Devicare Launches Lit-Control in the US with Diem Labs". |
2019-05-03 |
| Devicare S.L.. (9/5/19). "Press Release: The PREVENTLIT Study Shows that Lit-Control Reduces new Episodes of Renal Lithiasis in Patients". Cerdanyola del Vallès. |
2019-09-05 |
| Devicare S.L.. (9/6/18). "Press Release: Devicare Gets the Patent for Its Sensor Technology in Europe and USA". |
2018-09-06 |
| ERS Genomics Ltd.. (2/16/21). "Press Release: ERS Genomics and ZeClinics Sign CRISPR/Cas9 License Agreement". Dublin & Barcelona. |
2021-02-16 |
| Esteve Pharmaceuticals, S.A.. (1/8/20). "Press Release: Esteve Acquires German Proprietary, Specialty, Hospital-focused Company Riemser and Expands Its Presence in Europe". |
2020-01-08 |
| Eurofins Scientific. (7/27/18). "Press Release: Eurofins Becomes the Market Leader in Food Testing Services in Spain with the Acquisition of Ecosur". |
2018-07-27 |
| European Invesmtent Bank (EIB). (9/7/18). "Press Release: Investment Plan for Europe – the EIB and Grifols Sign a New Loan Agreement to Advance Research on Rare and Chronic Diseases". |
2018-09-07 |
| Evotec AG. (9/17/18). "Press Release: Evotec and Almirall Enter into Research Collaboration in the Field of Dermatiological Diseases". Hamburg & Barcelona. |
2018-09-17 |
| Evotec SE. (5/19/22). "Press Release: Evotec and Almirall Enter into a Multi-target Alliance in Medical Dermatology". Hamburg & Barcelona. |
2022-05-19 |
| Gain Therapeutics SA. (2/26/19). "Press Release: Gain Therapeutics SA Announces Award of Grant Support from Leading Parkinson’s Research Foundations to Advance Its Proprietary Non Competitive Molecular Chaperones for Parkinson’s Disease". Lugano & Barcel |
2019-02-26 |
| Galapagos N.V.. (5/29/19). "Press Release: Gilead and Galapagos to Present Latest Data on Filgotinib at the Annual European Congress of Rheumatology (EULAR 2019)". Foster City, CA & Mechelen. |
2019-05-29 |
| Galecto Biotech AB. (10/26/18). "Press Release: Galecto Biotech Raises €79 Million in Series C Financing Co-Led by Ysios Capital and OrbiMed to Advance Galectin Inhibitor to Late-Stage Clinical Development". Copenhagen. |
2018-10-26 |
| Genomica SAU. (1/18/18). "Press Release: Genomica Opens Its First Subsidiary in China". Madrid. |
2018-01-18 |
| GoodGut. (1/18/18). "Press Release: GoodGut Does Trials on More Effective Test to Prevent Colon Cancer". Girona. |
2018-01-18 |
| Grifols S.A.. (1/23/19). "Press Release: Grifols Announces Collaboration and License Agreement with Rigel Pharmaceuticals to Commercialize Fostamatinib in Europe". Barcelona. |
2019-01-23 |
| Grifols S.A.. (11/17/17). "Press Release: FDA Approval of Genetic Test for Alpha-1 Deficiency and EMA Approval of Fibrin Sealant". Barcelona. |
2017-11-17 |
| Grifols S.A.. (11/24/20). "Press Release: Strategic Alliance between Grifols and the Egyptian Government to Boost Plasma-derived Medicines Self-sufficiency in the Middle East and Africa". Barcelona. |
2020-11-24 |
| Grifols S.A.. (2/18/20). "Press Release: Grifols and the Public Investment Fund of Saudi Arabia Taking Steps to Boost Plasma Medicines Self-supply in the Region". Barcelona. |
2020-02-18 |
| Grifols S.A.. (2/28/18). "Press Release: Grifols Revenues Exceed EUR 4,300 Million and Reported Profit Reaches EUR 663 Million". Barcelona. |
2018-02-28 |
| Grifols S.A.. (2/7/19). "Press Release: Grifols Receives FDA Approval for Procleix Babesia Assay for Donor Screening on Procleix Panther System". Barcelona. |
2019-02-07 |
| Grifols S.A.. (3/20/18). "Press Release: Grifols Expands and Diversifies Its Plasma Collection Network with the Acquisition of 35 Donation Centers in Germany from Aton". Barcelona. |
2018-03-20 |
| Grifols S.A.. (5/10/18). "Press Release: Grifols Reaches an Agreement with Boya Bio-Pharmaceutical to Open Plasma Collection Centers in China". Barcelona. |
2018-05-10 |
| Grifols S.A.. (7/27/18). "Press Release: First Half 2018 Results. Grifols Increases Net Profits by 15% to EUR 319 Million, with Sustained Operational Revenue Growth of 7%". Barcelona. |
2018-07-27 |
| Grifols S.A.. (7/28/17). "Press Release: Grifols Increases Its Revenues by 12.3% to EUR 2,192 Million Driven by Growth of Its Main Divisions". Barcelona. |
2017-07-28 |
| Grifols S.A.. (7/31/19). "Press Release: Grifols Increases Its Revenues by 14.3% to EUR 2,423 million, Driven by Its Strategic Growth Plan". Barcelona. |
2019-07-31 |
| Grifols S.A.. (7/5/17). "Press Release: Grifols Strengthens Its R&D+i through Investee Companies. Grifols Opens New Lines of Research with the Acquisition of a 44% Stake in GigaGen for USD 35 Million". Barcelona. |
2017-07-05 |
| Grifols S.A.. (9/17/21). "Press Release: Grifols Acquires Tiancheng Pharmaceutical Holdings, the Largest Shareholder of Biotest, to Increase Patients’ Access to Plasma Therapies". Barcelona. |
2021-09-17 |
| Grifols S.A.. (9/7/20). "Press Release: Grifols to Acquire Alkahest to Enhance Discovery Research and Development". Barcelona & San Carlos, CA. |
2020-09-07 |
| Idoven 1903, S.L.. (4/30/22). "Press Release: Idoven Receives €6.5 Million of Funding from the European Innovation Council". |
2022-04-30 |
| Idoven 1903, S.L.. (6/21/22). "Press Release: Idoven Raises €18.5 Million to Continue Revolutionizing Cardiovascular Disease Detection and Prevention with AI". |
2022-06-21 |
| ImCheck Therapeutics SAS. (7/18/19). "Press Release: ImCheck Therapeutics Appoints Paul Frohna MD, PhD, PharmD, as Chief Medical Officer". Marseille. |
2019-07-18 |
| IMIdomics S.L.. (5/31/17). "Press Release: IMIDomics SL and Celgene Corporation Enter into Strategic Collaboration to Advance the Development of Novel Treatments for Patients with Immune-mediated Inflammatory Diseases". Barcelona. |
2017-05-31 |
| Inbrain Neuroelectronics S.L.. (3/26/21). "Press Release: Inbrain Neuroelectronics Raises Over €14M Series A". Barcelona. |
2021-03-26 |
| Innate Pharma S.A.. (9/23/19). "Press Release: Innate Pharma Announces Clinical Data Presentations on IPH5401 and Monalizumab at ESMO 2019". Marseille. |
2019-09-23 |
| Integra Thepeutics S.L.. (12/2/21). "Press Release: Integra Tx Secures €4.5 Million in Funding from Advent France Biotechnology, Invivo Capital and Takeda Ventures". Barcelona. |
2021-12-02 |
| Integra Thepeutics S.L.. (2/21/22). "Press Release: Integra Therapeutics Appoints Recognized Geneticist George Church to Its Scientific Advisory Board". Barcelona. |
2022-02-21 |
| Integra Thepeutics S.L.. (3/29/22). "Press Release: Integra Therapeutics Closes a New Investment of €1.5 Million with the Addition of Columbus Venture Partners to Seed Round". Barcelona. |
2022-03-29 |
| Invent Farma Holding Spain S.L.. (6/21/17). "Press Release: Invent Farma / Neuraxpharm Group Announces the Acquisition of FB Health in Italy". Barcelona & Düsseldorf. |
2017-06-21 |
| Invivo Partners. (3/5/24). "Press Release: Invivo Partners Is Preparing to Launch a €100M Invivo Ventures III Fund to Invest in Leading-edge Life Sciences". Barcelona. |
2024-03-05 |
| Ion Beam Applications S.A. (IBA). (12/8/22). "Press Release: IBA Wins 10 Proton Therapy System Contract in Spain". Louvain-la-Neuve. |
2022-12-08 |
| Iproteos S.L.. (1/26/17). "Press Release: Grant of 700,000 € for the Discovery of Drugs against Atherosclerosis". |
2017-01-26 |
| IRB Barcelona. (5/21/19). "Press Release: The IRB Barcelona Spin-off Ona Therapeutics Hits the Road Thanks to Sabadell Asabys". |
2019-05-21 |
| Keensight Capital. (7/23/19). "Press Release: Keensight Capital Acquires 3P Biopharmaceuticals to Accelerate Its Global Growth Strategy". Paris. |
2019-07-23 |
| Kymos S.L.. (9/28/20). "Press Release: Kymos and Prolytic Merge to Become Kymos Group". Barcelona & Frankfurt a.M.. |
2020-09-28 |
| Laboratoris Sanifit S.L.. (1/8/18). "Press Release: Sanifit Announces the Appointment of Cris Calsada as Chief Financial Officer". Palma & San Diego, CA. |
2018-01-08 |
| Laboratoris Sanifit S.L.. (3/6/18). "Press Release: Sanifit Announces Results of the Phase II Clinical Trial of SNF472 in Patients with Calciphylaxis". Palma & San Diego, CA. |
2018-03-06 |
| Laboratoris Sanifit S.L.. (6/26/19). "Press Release: Sanifit Announces €72.2M ($80.9M) Financing in Spain’s Largest Private Biotech Fundraise". Palma & San Diego, CA. |
2019-06-26 |
![[LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal](/images/basics/lse-life-sciences-europe-portal-logo.svg){kind=logo}
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
